The Asia Pacific Endoscope Reprocessing Market would witness market growth of 9.8% CAGR during the forecast period (2024-2031).
The China market dominated the Asia Pacific Endoscope Reprocessing Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $200.9 million by 2031. The Japan market is registering a CAGR of 9.1% during (2024 - 2031). Additionally, The India market would showcase a CAGR of 10.5% during (2024 - 2031).
The endoscope reprocessing market has witnessed significant growth in recent years, driven by several factors. The escalating incidence of chronic diseases, as well as the subsequent surge in the global endoscopic procedure volume, constitute a significant catalyst.
Moreover, as per the World Health Organisation (WHO), noncommunicable diseases (NCDs) are responsible for the demise of 41 million people annually, which accounts for 74% of the total global mortality. Each year, 17 million individuals under the age of 70 succumb to an NCD.
The rapid increase in lifestyle-related diseases has led to a substantial rise in endoscopic procedures in Asia Pacific. For example, in Japan, the high incidence of gastric cancer has made endoscopy a routine part of medical examinations for many individuals. According to recent reports in Japan, the risk of cumulative incidence of gastric cancer was 17.0% in men and 7.7% in women in the H. pylori-infected population and < 1% in the non-infected population. More than 99% of gastric cancers in Japan are associated with H. pylori-infection gastritis.
Based on End-use, the market is segmented into Outpatient Facilities and Hospitals. Based on Product, the market is segmented into High-level Disinfectants & Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AERs), Endoscope Drying, Storage, & Transport Systems and Others. Based on Automated Endoscope Reprocessors (AERs) Type, the market is segmented into Single Basin and Double Basin. Based on Automated Endoscope Reprocessors (AERs) Portability, the market is segmented into Standalone AER and Portable AER. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The China market dominated the Asia Pacific Endoscope Reprocessing Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $200.9 million by 2031. The Japan market is registering a CAGR of 9.1% during (2024 - 2031). Additionally, The India market would showcase a CAGR of 10.5% during (2024 - 2031).
The endoscope reprocessing market has witnessed significant growth in recent years, driven by several factors. The escalating incidence of chronic diseases, as well as the subsequent surge in the global endoscopic procedure volume, constitute a significant catalyst.
Moreover, as per the World Health Organisation (WHO), noncommunicable diseases (NCDs) are responsible for the demise of 41 million people annually, which accounts for 74% of the total global mortality. Each year, 17 million individuals under the age of 70 succumb to an NCD.
The rapid increase in lifestyle-related diseases has led to a substantial rise in endoscopic procedures in Asia Pacific. For example, in Japan, the high incidence of gastric cancer has made endoscopy a routine part of medical examinations for many individuals. According to recent reports in Japan, the risk of cumulative incidence of gastric cancer was 17.0% in men and 7.7% in women in the H. pylori-infected population and < 1% in the non-infected population. More than 99% of gastric cancers in Japan are associated with H. pylori-infection gastritis.
Based on End-use, the market is segmented into Outpatient Facilities and Hospitals. Based on Product, the market is segmented into High-level Disinfectants & Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AERs), Endoscope Drying, Storage, & Transport Systems and Others. Based on Automated Endoscope Reprocessors (AERs) Type, the market is segmented into Single Basin and Double Basin. Based on Automated Endoscope Reprocessors (AERs) Portability, the market is segmented into Standalone AER and Portable AER. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
List of Key Companies Profiled
- Belimed AG (Metall Zug AG)
- ASP Global Manufacturing GmbH (FORTIVE CORPORATION)
- Ecolab, Inc.
- Getinge AB
- Steelco S.p.A. (Miele Group)
- ARC Healthcare Solutions Inc.
- Metrex Research, LLC (Envista Holdings Corporation)
- Shinva Medical Instrument Co., Ltd.
Market Report Segmentation
By End-use- Outpatient Facilities
- Hospitals
- High-level Disinfectants & Test Strips
- Detergents & Wipes
- Automated Endoscope Reprocessors (AERs)
- Type
- Single Basin
- Double Basin
- Portability
- Standalone AER
- Portable AER
- Endoscope Drying, Storage, & Transport Systems
- Others
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Asia Pacific Endoscope Reprocessing Market by End-use
Chapter 5. Asia Pacific Endoscope Reprocessing Market by Product
Chapter 6. Asia Pacific Endoscope Reprocessing Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Belimed AG (Metall Zug AG)
- ASP Global Manufacturing GmbH (FORTIVE CORPORATION)
- Ecolab, Inc.
- Getinge AB
- Steelco S.p.A. (Miele Group)
- ARC Healthcare Solutions Inc.
- Metrex Research, LLC (Envista Holdings Corporation)
- Shinva Medical Instrument Co., Ltd.
Methodology
LOADING...
